MedTrace Logo

Oocyte Survival After Vitrification in an Open or Closed Device With Closed Storage.

NCT01952184 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2015-12-03

No results posted yet for this study

Summary

The survival rate (and embryo quality) of donor oocytes with two commercially available devices.

Conditions

  • Survival
  • Embryo Quality

Interventions

DEVICE

CBSvit HS device

closed vitrification with closed storage

DEVICE

Cryotop SC device

open vitrification with closed storage

Sponsors & Collaborators

  • Universitair Ziekenhuis Brussel

    lead OTHER

Principal Investigators

  • Neelke De Munck, MSc. · Centrum voor Reproductieve Geneeskunde, UZBrussel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
36 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-09-30
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01952184 on ClinicalTrials.gov